ArticleBreast cancer research and treatment2026

Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer.

Catherine Doyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.